Antenatal inflammation induced TGF-β1 but suppressed CTGF in preterm lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 1, 2007, Pages

  Kunzmann, Steffen ^a   Speer, Christian P ^a   Jobe, Alan H ^b   Kramer, Boris W ^a,c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bronchopulmonary dysplasia; Chorioamnionitis; Fibrosis; Smad signaling

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ENDOTOXIN; SMAD2 PROTEIN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; FETUS LUNG MATURATION; GESTATION PERIOD; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROSIS; NONHUMAN; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENDOTOXINS; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INFANT, NEWBORN; INFANT, PREMATURE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; PREGNANCY; RNA, MESSENGER; SHEEP; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33846200439     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00159.2006     Document Type: Article

References (55)

1. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis." Am J Respir Crit Care Med 164: 1755-1756, 2001.
2. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, and Leask A. Tumor necrosis factor-α suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts. J Biol Chem 275: 15220-15225, 2000.
3. Abreu JG, Ketpura NI, Reversade B, and De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4: 599-604, 2002.
4. Bartram U and Speer CP. The role of transforming growth factor-β in lung development and disease. Chest 125: 754-765, 2004.
5. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
6. Blom IE, Goldschmeding R, and Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21: 473-482, 2002.
7. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5: 153-165, 2002.
8. Bry K and Lappalainen U. Intra-amniotic endotoxin accelerates lung maturation in fetal rabbits. Acta Paediatr 90: 74-80, 2001.
9. Bry K and Lappalainen U. Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1β in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Semin Perinatol 30: 121-128, 2006.
10. Bry K, Lappalainen U, and Hallman M. Intra-amniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 99: 2992-2999, 1997.
11. Burgess JK, Ge Q, Poniris MH, Boustany S, Twigg SM, Black JL, and Johnson PR. Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am J Physiol Lung Cell Mol Physiol 290: L153-L161, 2006.
12. Cao L, Liu C, Cai B, Jia X, Kang L, Speer CP, and Sun B. Nuclear factor-κB expression in alveolar macrophages of mechanically ventilated neonates with respiratory distress syndrome. Biol Neonate 86: 116-123, 2004.
13. Charafeddine L, D'Angio CT, and Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 103: 759-765, 1999.
14. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8: 73-81, 2003.
15. D'Alquen D, Kramer BW, Seidenspinner S, Marx A, Berg D, Groneck P, and Speer CP. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 57: 263-269, 2005.
16. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, and Warburton D. Transfer of the active form of transforming growth factor-β1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163: 2575-2584, 2003.
17. Gobet R, Park JM, Nguyen HT, Chang B, Cisek LJ, and Peters CA. Renal renin-angiotensin system dysregulation caused by partial bladder outlet obstruction in fetal sheep. Kidney Int 56: 1654-1661, 1999.
18. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, and Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 179: 194-202, 1998.
19. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, and Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93: 712-718, 1994.
20. Grotendorst GR, Okochi H, and Hayashi N. A novel transforming growth factor-β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7: 469-480, 1996.
21. Guidot DM, Folkesson HG, Jain L, Sznajder JI, Pittet JF, and Matthay MA. Integrating acute lung injury and regulation of alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol 291: L301-L306, 2006.
22. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
23. Ikegami M, Kallapur SG, and Jobe AH. Initial responses to ventilation of premature lambs exposed to intra-amniotic endotoxin 4 days before delivery. Am J Physiol Lung Cell Mol Physiol 286: L573-L579, 2004.
24. Ikegami M, Moss TJ, Kallapur SG, Mulrooney N, Kramer BW, Nitsos I, Bachurski CJ, Newnham JP, and Jobe AH. Minimal lung and systemic responses to TNF-α in preterm sheep. Am J Physiol Lung Cell Mol Physiol 285: L121-L129, 2003.
25. Jobe AH and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723-1729, 2001.
26. Jobe AH, Newnham JP, Willet KE, Moss TJ, Gore Ervin M, Padbury JF, Sly P, and Ikegami M. Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol. Am J Respir Crit Care Med 162: 1656-1661, 2000.
27. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641-643, 1999.
28. Jonsson B, Li YH, Noack G, Brauner A, and Tullus K. Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 89: 1375-1380, 2000.
29. Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, and Jobe AH. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol 287: L1178-L1185, 2004.
30. Kallapur SG, Nitsos I, Moss TJ, Kramer BW, Newnham JP, Ikegami M, and Jobe AH. Chronic endotoxin exposure does not cause sustained structural abnormalities in the fetal sheep lungs. Am J Physiol Lung Cell Mol Physiol 288: L966-L974, 2005.
31. Kallapur SG, Willet KE, Jobe AH, Ikegami M, and Bachurski CJ. Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am J Physiol Lung Cell Mol Physiol 280: L527-L536, 2001.
32. Khalil N. Posttranslational activation of latent transforming growth factor-β (L-TGF-β): clinical implications. Histol Histopathol 16: 541-551, 2001.
33. Khalil N. TGF-β: from latent to active. Microbes Infect 1: 1255-1263, 1999.
34. Kotecha S, Wangoo A, Silverman M, and Shaw RJ. Increase in the concentration of transforming growth factor-β1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 128: 464-469, 1996.
35. Kramer BW, Kramer S, Ikegami M, and Jobe AH. Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 283: L452-L459, 2002.
36. Kramer BW, Moss TJ, Willet KE, Newnham JP, Sly PD, Kallapur SG, Ikegami M, and Jobe AH. Dose and time response after intra-amniotic endotoxin in preterm lambs. Am J Respir Crit Care Med 164: 982-988, 2001.
37. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, and Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
38. Lecart C, Cayabyab R, Buckley S, Morrison J, Kwong KY, Warburton D, Ramanathan R, Jones CA, and Minoo P. Bioactive transforming growth factor-β in the lungs of extremely low birth weight neonates predicts the need for home oxygen supplementation. Biol Neonate 77: 217-223, 2000.
39. May M, Marx A, Seidenspinner S, and Speer CP. Apoptosis and proliferation in lungs of human fetuses exposed to chorioamnionitis. Histopathology 45: 283-290, 2004.
40. May M, Strobel P, Preisshofen T, Seidenspinner S, Marx A, and Speer CP. Apoptosis and proliferation in lungs of ventilated and oxygen-treated preterm infants. Eur Respir J 23: 113-121, 2004.
41. Moussad EE and Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab 71: 276-292, 2000.
42. Newnham JP, Shub A, Jobe AH, Bird PS, Ikegami M, Nitsos I, and Moss TJ. The effects of intra-amniotic injection of periodontopathic lipopolysaccharides in sheep. Am J Obstet Gynecol 193: 313-321, 2005.
43. Northway WH Jr, Rosan RC, and Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
44. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 8: 29-38, 2003.
45. Speer CP. Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Paediatr Respir Rev 5 Suppl A: S241-S244, 2004.
46. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA, Bauer CR, Stoll BJ, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF, Ehrenkranz RA, and Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 179: 1632-1639, 1998.
47. Ten Dijke P and Hill CS. New insights into TGF-β-Smad signalling. Trends Biochem Sci 29: 265-273, 2004.
48. Thomas W and Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Hum Dev 81: 155-163, 2005.
49. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, and Leviton A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105: 1194-1201, 2000.
50. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, and Elias JA. Conditional overexpression of bioactive transforming growth factor-β1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31: 650-656, 2004.
51. Watterberg KL, Demers LM, Scott SM, and Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97: 210-215, 1996.
52. Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, and Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 48: 782-788, 2000.
53. Willet KE, Kramer BW, Kallapur SG, Ikegami M, Newnham JP, Moss TJ, Sly PD, and Jobe AH. Intra-amniotic injection of IL-1 induces inflammation and maturation in fetal sheep lung. Am J Physiol Lung Cell Mol Physiol 282: L411-L420, 2002.
54. Workalemahu G, Foerster M, Kroegel C, and Braun RK. Human γδ-T lymphocytes express and synthesize connective tissue growth factor: effect of IL-15 and TGF-β1 and comparison with αβ-T lymphocytes. J Immunol 170: 153-157, 2003.
55. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, and Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177: 825-830, 1997.